MiR-29b-1-5p is altered in BRCA1 mutant tumours and is a biomarker in basal-like breast cancer
Open Access
- 11 September 2018
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 9 (71) , 33577-33588
Abstract
MiR-29b-1-5p is altered in BRCA1 mutant tumours and is a biomarker in basal-like breast cancer MiR-29b-1-5p is altered in BRCA1 mutant tumours and is a biomarker in basal-like breast cancerKeywords
All Related Versions
This publication has 51 references indexed in Scilit:
- Persistent Activation of NF-κB in BRCA1-Deficient Mammary Progenitors Drives Aberrant Proliferation and Accumulation of DNA DamageCell Stem Cell, 2016
- Genome‐wide analysis reveals a role for BRCA1 and PALB2 in transcriptional co‐activationThe EMBO Journal, 2014
- microRNA expression profiling identifies a four microRNA signature as a novel diagnostic and prognostic biomarker in triple negative breast cancersOncotarget, 2014
- The Deubiquitinase USP28 Stabilizes LSD1 and Confers Stem-Cell-like Traits to Breast Cancer CellsCell Reports, 2013
- The basal-like mammary carcinomas induced by Brca1 or Bard1 inactivation implicate the BRCA1/BARD1 heterodimer in tumor suppressionProceedings of the National Academy of Sciences, 2008
- A Mammalian microRNA Expression Atlas Based on Small RNA Library SequencingCell, 2007
- Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumorsGenome Biology, 2007
- Brca1 inactivation induces p27Kip1-dependent cell cycle arrest and delayed development in the mouse mammary glandOncogene, 2004
- Multiple genetic changes are associated with mammary tumorigenesis in Brca1 conditional knockout miceOncogene, 2001
- Cluster analysis and display of genome-wide expression patternsProceedings of the National Academy of Sciences, 1998